COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study.
Patel NJ, D'Silva KM, Hsu TY, DiIorio M, Fu X, Cook C, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Zhang Y, Sparks JA, Wallace ZS.
Patel NJ, et al.
medRxiv [Preprint]. 2021 Aug 9:2021.08.05.21261643. doi: 10.1101/2021.08.05.21261643.
medRxiv. 2021.
PMID: 34401883
Free PMC article.
Updated.
Preprint.